Home > PE Ratio > MOREPEN LABORATORIES

MOREPEN LABORATORIES
PE (Price/Earnings) Ratio

The Current P/E Ratio of MOREPEN LABORATORIES is 28.82.

Share Price ₹62.1Jul 01,2025
Market Cap ₹3,401.4 Cr
Earnings-TTM₹118.0 CrTTM-Consolidated Results
Price/Earnings28.82xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for MOREPEN LABORATORIES
Please provide your vote to see the results

Definition & Calculation of PE (Price/Earnings) ratio of MOREPEN LABORATORIES

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of MOREPEN LABORATORIES is calculated as :

Current Market Cap [ ₹3,401.4 Cr] as on Jul 01,2025

(/) Earnings [ ₹118.0 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 28.82x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for MOREPEN LABORATORIES , the investors are currently willing to pay 28.82 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of MOREPEN LABORATORIES !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of MOREPEN LABORATORIES over the last five years.

Historical PE (Price/Earnings) ratio chart of MOREPEN LABORATORIES


PE Ratio Performance Analysis for MOREPEN LABORATORIES

- MOREPEN LABORATORIES 's latest p/e ratio is 28.82x.

- MOREPEN LABORATORIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 20.23x.

- MOREPEN LABORATORIES 's operated at median p/e ratio of 17.2x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, MOREPEN LABORATORIES 's p/e ratio peaked in Mar2023 at 33.94x.

- MOREPEN LABORATORIES 's p/e ratio hit its five-year low in Mar2020 of 12.78x.


How does MOREPEN LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
MOREPEN LABORATORIES 118.0228.823,401.4
SUN PHARMACEUTICAL INDUSTRIES LTD10,980.1036.43400,017.0
DIVIS LABORATORIES LTD2,191.0083.01181,867.0
CIPLA LTD5,291.0523.14122,451.0
TORRENT PHARMACEUTICALS LTD1,911.0060.50115,620.0
DR REDDYS LABORATORIES LTD5,703.5018.69106,572.0
MANKIND PHARMA LTD2,003.2247.1694,465.4
ZYDUS LIFESCIENCES LTD4,614.8021.84100,769.0
LUPIN LTD3,306.2627.0989,575.7
AUROBINDO PHARMA LTD3,515.2618.7165,775.8
ABBOTT INDIA LTD1,414.4452.1373,729.8

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs MOREPEN LABORATORIES 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 18.69x
Max industry PE 83.01x
Median industry PE 28.82x
Average industry PE 37.96x



You may also like the below Video Courses